Document 0527 DOCN M9590527 TI T cells made deficient in interleukin-2 production by exposure to staphylococcal enterotoxin B in vivo are primed for interferon-gamma and interleukin-10 secretion. DT 9509 AU Florquin S; Amraoui Z; Goldman M; Laboratoire Pluridisciplinaire de Recherche Experimentale; Biomedicale, Hopital Erasme, Universite Libre de Bruxelles,; Belgium. SO Eur J Immunol. 1995 May;25(5):1148-53. Unique Identifier : AIDSLINE MED/95293004 AB The superantigen staphylococcal enterotoxin B (SEB) induces a defect in interleukin (IL)-2 production by T cells expressing specific T cell receptor V beta domains. The present study was undertaken to determine the capacity of T cells, made deficient in IL-2 production by exposure to SEB in vivo, to secrete interferon (IFN)-gamma and IL-10 and to induce pathology upon SEB rechallenge. For this purpose, BALB/c mice received two intraperitoneal injections of 100 micrograms SEB with a 48-h interval. First, we compared peak serum levels of IL-2, IFN-gamma and IL-10 after SEB rechallenge with those measured after a single SEB injection in control mice. The expected defect in IL-2 production in SEB-pretreated mice was associated with a major increase in IL-10 and IFN-gamma levels which were about fivefold higher than in controls. Experiments in mice depleted of CD4+ or CD8+ cells as well as studies in which purified T cell populations were rechallenged with SEB in vitro indicated that both CD4+ and CD8+ cells from SEB-pretreated mice were primed for IL-10 and IFN-gamma production. Furthermore, SEB-pretreated mice were sensitized to the toxic effects of the superantigen as indicated by a 30-70% lethality rate (vs. 0% in naive mice) within 48 h after SEB rechallenge. IFN-gamma was involved in the lethal syndrome as it could be prevented by injection of neutralizing anti-IFN-gamma monoclonal antibody. We conclude that SEB-reactive T cells made deficient for the production of IL-2 by exposure to SEB in vivo are primed for IFN-gamma and IL-10 production, and that IFN-gamma up-regulation is involved in the shock syndrome occurring upon SEB rechallenge. DE Animal Base Sequence CD4-Positive T-Lymphocytes/DRUG EFFECTS/SECRETION CD8-Positive T-Lymphocytes/DRUG EFFECTS/SECRETION Enterotoxins/*PHARMACOLOGY/TOXICITY Immune Tolerance Interferon Type II/BIOSYNTHESIS/*SECRETION Interleukin-10/BIOSYNTHESIS/*SECRETION Interleukin-2/*DEFICIENCY/GENETICS Mice Mice, Inbred BALB C Molecular Sequence Data Receptors, Antigen, T-Cell, alpha-beta Specific Pathogen-Free Organisms Superantigens/*PHARMACOLOGY Support, Non-U.S. Gov't T-Lymphocyte Subsets/*DRUG EFFECTS/SECRETION JOURNAL ARTICLE SOURCE: National Library of Medicine. NOTICE: This material may be protected by Copyright Law (Title 17, U.S.Code).